BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15024201)

  • 1. Argyrophilic staining of nucleolar organizer region count and morphometry in benign and malignant melanocytic lesions.
    Tuccari G; Giuffrè G; Lentini M; Batolo D; Catalano A
    Am J Dermatopathol; 2004 Apr; 26(2):171-2; author reply 172-3. PubMed ID: 15024201
    [No Abstract]   [Full Text] [Related]  

  • 2. Argyrophilic staining of nucleolar organizer region count and morphometry in benign and malignant melanocytic lesions.
    Li LX; Crotty KA; Palmer AA; Kril JJ; Scolyer RA; Thompson JF; McCarthy SW
    Am J Dermatopathol; 2003 Jun; 25(3):190-7. PubMed ID: 12775980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Argyrophilic nucleolar organizer region counts in malignant melanoma associated with benign intradermal nevus.
    Pich A; Aloi F; Margaria E; Tomasini C
    Dermatologica; 1991; 183(4):246-50. PubMed ID: 1809585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleolar organizer regions argyrophilic associated proteins in cutaneous melanocytic lesions.
    Reis JP; Tellechea O; Baptista AP
    Dermatologica; 1991; 183(2):136-8. PubMed ID: 1743375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silver staining nucleolar organiser region (AgNOR) study in melanocytic skin tumours.
    Naik R; Raghuveer CV; Jacob DL
    J Indian Med Assoc; 1997 Jul; 95(7):420-1. PubMed ID: 9425842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of nucleolar organizer region staining in the differential diagnosis of borderline melanocytic lesions.
    Fallowfield ME; Cook MG
    Histopathology; 1989 Mar; 14(3):299-304. PubMed ID: 2468598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinguishing benign and malignant melanocytic lesions with the AgNOR method.
    Friedman RJ; Grin CM; Heilman E; Weiser J; Gottlieb GJ; Waldo E; Rigel DS; Kopf AW
    Dermatol Clin; 1991 Oct; 9(4):689-93. PubMed ID: 1934643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AgNOR (nucleolar organizer regions) staining in malignant melanoma.
    Nagatani T; Iemoto G; Miyakawa K; Ichiyama S; Takahashi Y; Uchiyama M; Nakajima H
    J Dermatol; 1991 Dec; 18(12):731-5. PubMed ID: 1806604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The nucleolus organizer region in benign and malignant melanocyte lesions of the skin: a quantitative study].
    Sementa AR; Gambini C; Borgiani L; Palladino M; Corso M; Canepa M
    Pathologica; 1989; 81(1073):231-7. PubMed ID: 2484303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleolar organizer region count and subjective AgNOR pattern assessment (SAPA) score in skin tumors.
    Khanna AK; Giri AK; Khanna A; Kumar M
    J Surg Oncol; 2001 Dec; 78(4):273-8. PubMed ID: 11745824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A; Chiusa L; Margaria E
    Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleolar organizer regions in iris nevi and melanomas.
    Marcus DM; Mawn LA; Egan KM; Albert DM
    Am J Ophthalmol; 1992 Aug; 114(2):202-7. PubMed ID: 1642296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of argyrophilic nucleolar organizer region quantification in benign and malignant bone tumors.
    Clohisy JC; Schajowicz F; Vaziri DM; McDonald DJ; Connolly TJ; Sotelo-Avila C; Betts JE
    Clin Orthop Relat Res; 1995 Jan; (310):229-36. PubMed ID: 7641444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on morphological typing of argyrophilic nucleolar organizer regions.
    Xu LZ; Zhu WP; Chen G
    Pathol Int; 1995 Nov; 45(11):860-5. PubMed ID: 8581149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical value of interphase argyrophilic nucleolar organiser regions in transitional cell bladder tumours.
    Metze K; Cia EM; Trevisan MA
    Mol Pathol; 2001 Jun; 54(3):200. PubMed ID: 11376137
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognosing melanomas: the argyrophilic nucleolar organizer region approach.
    Rebora A
    Dermatology; 1992; 185(3):166-8. PubMed ID: 1446080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on diagnostic value of analyzing argyrophilic nucleolar organizer regions in benign and malignant pleural effusions].
    Jiang S; Zeng Z; Liao Z
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):34-6. PubMed ID: 11263298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleolar organizer regions in malignant melanoma and melanocytic nevi. Comparison of two counting methods.
    Di Gregorio C; Losi L; Annessi G; Botticelli A
    Am J Dermatopathol; 1991 Aug; 13(4):329-33. PubMed ID: 1928617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Quantitative evaluation of AgNORs in bone tumours.
    Tuccari G; Ofner D; Rüschoff J
    Pathology; 2003 Oct; 35(5):455-6. PubMed ID: 14555396
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: quantitative evaluation of AgNORs in bone tumours.
    Arora B; Kumar S; Jindal K
    Pathology; 2004 Feb; 36(1):98. PubMed ID: 14757570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.